London
· Delayed Price · Currency is GBP · Price in GBX LungLife AI Statistics
Total Valuation
LungLife AI has a market cap or net worth of GBP 689,819. The enterprise value is -1.22 million.
| Market Cap | 689,819 |
| Enterprise Value | -1.22M |
Important Dates
The next estimated earnings date is Thursday, May 22, 2025.
| Earnings Date | May 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.67% |
| Shares Change (QoQ) | +11.33% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 17.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 30.06 |
| PB Ratio | 0.11 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.34 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.35 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.83 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -140.09 |
Financial Efficiency
Return on equity (ROE) is -48.59% and return on invested capital (ROIC) is -30.30%.
| Return on Equity (ROE) | -48.59% |
| Return on Assets (ROA) | -27.28% |
| Return on Invested Capital (ROIC) | -30.30% |
| Return on Capital Employed (ROCE) | -57.70% |
| Revenue Per Employee | 2,868 |
| Profits Per Employee | -441,825 |
| Employee Count | 15 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 6.05 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 5.48 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LungLife AI had revenue of GBP 22,947 and -3.53 million in losses. Loss per share was -0.13.
| Revenue | 22,947 |
| Gross Profit | 22,947 |
| Operating Income | -3.66M |
| Pretax Income | -3.53M |
| Net Income | -3.53M |
| EBITDA | -3.45M |
| EBIT | -3.66M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 2.07 million in cash and 166,958 in debt, giving a net cash position of 1.91 million.
| Cash & Cash Equivalents | 2.07M |
| Total Debt | 166,958 |
| Net Cash | 1.91M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.28M |
| Book Value Per Share | 0.22 |
| Working Capital | 1.52M |
Cash Flow
In the last 12 months, operating cash flow was -3.37 million and capital expenditures -60,928, giving a free cash flow of -3.43 million.
| Operating Cash Flow | -3.37M |
| Capital Expenditures | -60,928 |
| Free Cash Flow | -3.43M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -15,941.26% |
| Pretax Margin | -15,389.54% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LungLife AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.67% |
| Shareholder Yield | -5.67% |
| Earnings Yield | -512.40% |
| FCF Yield | -497.94% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LungLife AI has an Altman Z-Score of -5.25. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.25 |
| Piotroski F-Score | n/a |